Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Verve Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:VERV | Benzinga

Q: What sector and industry does Verve Therapeutics (VERV) operate in?

Verve Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Verve Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VERV.

Open	$4.50
Close	-
Volume / Avg.	3.33M / 2.58M
Day Range	$4.37 - $5.50
52 Wk Range	2.86 - 9.31
Market Cap	$444.87M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	22.16%
Days to Cover	15.72

Recent News

Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Netflix, Ericsson, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Tuesday (CORRECTED)

Avi Kapoor

Verve Therapeutics Touts Positive Data From Gene Editing Medicine To Lower Cholesterol After Single Dose

Verve shares Phase 1b results of VERVE-102, showing dose-dependent LDL-C reductions and strong safety in patients with HeFH or premature CAD.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$4.50
Close	-
Volume / Avg.	3.33M / 2.58M
Day Range	$4.37 - $5.50
52 Wk Range	2.86 - 9.31
Market Cap	$444.87M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	22.16%
Days to Cover	15.72

About Verve Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardio...

Got Questions? Ask

Show VERV's technical analysis

What do VERV's technical indicators suggest?

What is VERV's all-time low price?

What is VERV's average daily volume?

What is the Pivot resistance level for VERV?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Verve Therapeutics (VERV) stock?

You can purchase shares of Verve Therapeutics (NASDAQ:VERV) through any online brokerage.

View our list of the best stock brokerages

Who are Verve Therapeutics (VERV) competitors?

Other companies in Verve Therapeutics’s space includes: Precigen (NASDAQ:PGEN), Cogent Biosciences (NASDAQ:COGT), Upstream Bio (NASDAQ:UPB), Celcuity (NASDAQ:CELC) and Prothena Corp (NASDAQ:PRTA).

What is the forecast, or price target, for Verve Therapeutics (VERV) stock?

Verve Therapeutics has a consensus price target of $31.13.

What is the current price for Verve Therapeutics (VERV)?

The stock price for Verve Therapeutics (NASDAQ: VERV) is $5.01 last updated April 21, 2025 at 12:00 PM EDT.

Does Verve Therapeutics (VERV) pay a dividend?

There are no upcoming dividends for Verve Therapeutics.

When is Verve Therapeutics (NASDAQ:VERV) reporting earnings?

Verve Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is Verve Therapeutics (VERV) going to split?

There is no upcoming split for Verve Therapeutics.

What sector and industry does Verve Therapeutics (VERV) operate in?

Verve Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Verve Therapeutics Stock Price, Quotes and Forecasts

Verve Therapeutics (VERV) Forecast